For the first time, scientists can now leverage the reproducibility of ioCells to study how the four major CNS cell types interact and contribute to neurological diseases. This enables more precise ...
Top: SEAMOUR, the robotic sea lion. Bottom: Its digital twin. A Drexel Engineering team has developed a highly accurate numerical model that predicts how their bio-robotic sea lion swims and maneuvers ...
CN Bio and Altis Biosystems, Inc. (“Altis”), leading developers of in vitro human organ models that optimize the accuracy and efficiency of drug development, today announced a strategic partnership.
Company and CMMI agreed to key terms to be offered to State Medicaid Agencies to support access to LYFGENIA™ gene therapy for sickle cell disease States can opt in to an outcomes-based agreement with ...
MINNEAPOLIS--(BUSINESS WIRE)--A recently published paper in Translational Lung Cancer Research details encouraging results from nonclinical studies conducted with Humanetics Corporation’s (Humanetics) ...
The business model will focus on selling 3D bio-printers and bio-inks designed to develop delicious, nutritious, safe, and consistent cultivated meat from ethically harvested cells. 3D bio-printers: ...
BLR Bio LLC has announced new data on BLR-200, its lead compound for systemic sclerosis and lung fibrosis. In the new study, BLR-200 demonstrated the ability to reduce key disease tissue markers for ...
Bitterroot Bio Inc. presented data on an anti-CD47 hybrid protein, BRB-002, tested in a murine model of atherosclerosis. BRB-002 was tested at 2.5 or 10 mg/kg i.p. 3x/week after a high-fat diet.
The previous blog briefly reviewed George Engel’s famous proposal for medicine to adopt a biopsychosocial lens. Being a holistic thinker, I support Engel’s call for medical professionals in general ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results